Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.
about
Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular ComplicationsTranscriptional regulation by the Set7 lysine methyltransferaseMitochondrial health, the epigenome and healthspanThe primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heartGenetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.Aberrant DNA methylation patterns in diabetic nephropathy(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells.Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature.Epigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathyEpigenetic mechanisms in diabetic complications and metabolic memory.Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes.Myocardin-Related Transcription Factor A Epigenetically Regulates Renal Fibrosis in Diabetic Nephropathy.Regulation of Nox enzymes expression in vascular pathophysiology: Focusing on transcription factors and epigenetic mechanisms.SET7/9 Enzyme Regulates Cytokine-induced Expression of Inducible Nitric-oxide Synthase through Methylation of Lysine 4 at Histone 3 in the Islet β CellGLP-1 Cleavage Product Reverses Persistent ROS Generation After Transient Hyperglycemia by Disrupting an ROS-Generating Feedback LoopEpigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic NephropathySIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands togetherThe Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes.Epigenetic modifications in the pathogenesis of diabetic nephropathySet7 mediated interactions regulate transcriptional networks in embryonic stem cells.Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice.Sustained kidney biochemical derangement in treated experimental diabetes: a clue to metabolic memory.Chromatin modifications associated with diabetes.Epigenetics of insulin resistance: an emerging field in translational medicine.Oxidative-stress-induced epigenetic changes in chronic diabetic complications.Glycemic memories and the epigenetic component of diabetic nephropathy.Metabolic memory: mechanisms and implications for diabetic vasculopathies.Deep sequencing reveals novel Set7 networks.Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications.Epigenetics and Cardiovascular Disease in Diabetes.Epigenetic Mechanisms in Diabetic Kidney Disease.Lysine Methyltransferase SETD7 (SET7/9) Regulates ROS Signaling through mitochondria and NFE2L2/ARE pathwayQuercus infectoria inhibits Set7/NF-κB inflammatory pathway in macrophages exposed to a diabetic environment.Epigenetic Changes in Diabetes and Cardiovascular Risk.Polycomb repressive complex 2 regulates MiR-200b in retinal endothelial cells: potential relevance in diabetic retinopathyHistone demethylase KDM1A represses inflammatory gene expression in preadipocytes.Diabetic kidney disease.Epigenetic changes in renal genes dysregulated in mouse and rat models of type 1 diabetes.Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes.Epigenetics in diabetic nephropathy, immunity and metabolism.
P2860
Q26859263-1BCE1A74-1FFC-461F-B654-1B5B72887F0FQ27009508-0A487E4A-E284-43ED-84C1-5A9AB763137FQ28391740-46A07D43-53B7-4B5E-A2CD-8928CE6B4E79Q28586308-1CA8B211-36DB-45BC-90D7-D21ABDD1CD04Q33660629-2AF3A8C8-444F-4EEC-B9F1-792C99D0182DQ33904741-E2B13035-C6BD-434B-9FD9-418C2548F423Q34144669-1A5D147C-25A2-4B5A-9117-2C06AABDFC49Q34350546-DEAB17AD-F063-4B18-89A2-1B619560BBF5Q34511162-55E367B2-CF06-44D4-AD70-BB2F34397783Q35071700-20E48330-A382-400D-AE16-06B204583849Q35645997-161963C8-6837-4189-A457-7890106E55D6Q35790594-0C428AEA-86D0-4872-9D39-666C2284FE21Q35849697-51643F7E-A7F8-42E6-A790-6EE81B3F4CCBQ35860498-BD768D70-82C2-42B1-9E1E-4E79E0D7E2DBQ35973918-E57EC661-5375-4B4E-A89B-D50A54715E1FQ36656799-56485FC1-1E4B-4937-A6B1-C6879255BFC3Q36867464-FE97FF07-36C6-476F-929F-F63A20C3B84FQ37051959-68593176-096E-4554-AC37-850F30B66311Q37158080-F30393D1-7E97-448F-89FB-C86F6A328D84Q37401060-960DEBB1-06EC-4DCE-9F64-396BC6DCF9FDQ37403354-192E27B8-FE06-4DCE-A0CF-2179AD1532F4Q37581782-F9E943FD-DF61-40D1-B1FE-7D733C096BB4Q38013734-6F5C8E6C-3EBA-4CE7-9C0A-825AC61A689DQ38073159-F4E954D1-7955-4275-B6FD-A93849D159B8Q38093867-BDE820C6-554B-4DF2-90B4-9A8FECE2C203Q38103744-CDB53C70-18B0-426A-80A2-B53071CD3E88Q38238034-36BC8982-713E-4195-8D9E-8B3DDE7C2322Q38476540-EBD49CEA-72C7-4FEB-887A-EA11290A40B0Q38524836-678D0A41-23DD-42DF-9D40-1CC3550FF858Q38605096-12C78275-9D57-4963-A0C2-72AB7A1774EFQ38747538-5B1D02D9-7957-4EAA-A1A8-DBB0386C233DQ38830359-D27A542C-3A56-4422-84F7-202579D1C648Q38837814-ABA861F1-BD56-4D9B-B457-545D757D4AF0Q38845518-FEE9320D-A9B8-42F5-B1F6-30F8A9EEEE4BQ38885853-747151FB-9404-475E-BDA7-021F68572032Q39164317-0356FE49-AA5D-4883-963A-91B2B27366E1Q43721013-502646CB-814F-4408-97B4-7255F26F7BCCQ44370140-D4728E07-664B-425C-85E9-9640EB05218FQ47159412-328E1A45-54E8-4FA4-97A4-B3981726964FQ47412518-CB15A05C-9E6C-4EEE-877C-57FE7F3AD0D9
P2860
Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.
@en
Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.
@nl
type
label
Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.
@en
Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.
@nl
prefLabel
Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.
@en
Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.
@nl
P2093
P50
P1433
P1476
Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.
@en
P2093
Chris Tikellis
Christian Orlowski
Mark E Cooper
P304
P356
10.1161/CIRCRESAHA.112.266171
P577
2012-03-08T00:00:00Z